Literature DB >> 22674404

A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer.

Junya Zhu1, Roger B Davis, Sherri O Stuver, Donna L Berry, Susan Block, Jane C Weeks, Saul N Weingart.   

Abstract

BACKGROUND: Although pain is common among patients with advanced cancer, little is known about longitudinal variability in pain intensity. For this report, the authors examined variability in pain intensity over 24 months among ambulatory patients with advanced stage cancers, associations between patient characteristics and within-patient pain variability, and the relation of pain variability to overall survival.
METHODS: The sample comprised 949 patients with solid tumors who received care and reported pain scores in at least 3 different months within 24 months of their initial stage IV diagnosis during the period from 2004 to 2006. Pain intensity was measured using a scale ranging from 0 (no pain) to 10 (worst pain). Pain variability was defined as the standard deviation of the maximum monthly pain scores and was dichotomized at the 50th percentile into high and low variability groups.
RESULTS: Considerable between-patient differences in pain variability (range, 0-5.77) were observed. Nonwhites, patients with a stage IV cancer diagnosed within the previous 3 months, and those with moderate or severe pain at baseline were more likely to experience high pain variability. Although patients with head and neck cancer generally had the highest pain variability, the intensity of their pain typically decreased over the disease course. High pain variability with worsening pain trajectory was associated with increased risk of death.
CONCLUSIONS: Longitudinally, pain intensity was highly variable among patients with stage IV cancer. Minority patients, newly diagnosed patients, patients with head and neck cancer, and patients with moderate or severe pain at baseline were at higher risk of large fluctuations in pain intensity.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 22674404     DOI: 10.1002/cncr.27673

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice.

Authors:  Marta Maddalo; Michela Buglione; Nadia Pasinetti; Luca Triggiani; Ludovica Pegurri; Alessandro Magli; Stefano M Magrini; Barbara A Murphy
Journal:  Radiol Med       Date:  2020-01-10       Impact factor: 3.469

Review 2.  Understanding the cancer pain experience.

Authors:  Judith A Schreiber
Journal:  Curr Pain Headache Rep       Date:  2014

3.  Determinants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02.

Authors:  Fengmin Zhao; Victor T Chang; Charles Cleeland; James F Cleary; Edith P Mitchell; Lynne I Wagner; Michael J Fisch
Journal:  J Clin Oncol       Date:  2013-12-23       Impact factor: 44.544

4.  Predictive factors for overall quality of life in patients with advanced cancer.

Authors:  Gemma Cramarossa; Edward Chow; Liying Zhang; Gillian Bedard; Liang Zeng; Arjun Sahgal; Vassilios Vassiliou; Takefumi Satoh; Palmira Foro; Brigette B Y Ma; Wei-Chu Chie; Emily Chen; Henry Lam; Andrew Bottomley
Journal:  Support Care Cancer       Date:  2013-01-22       Impact factor: 3.603

5.  Screening for Pain in the Ambulatory Cancer Setting: Is 0-10 Enough?

Authors:  Virginia T LeBaron; Traci M Blonquist; Fangxin Hong; Barbara Halpenny; Donna L Berry
Journal:  J Oncol Pract       Date:  2015-08-25       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.